Top 5 Stocks to Buy Now
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free LFWD Stock Alerts

Lifeward (LFWD) Competitors

Lifeward logo
$6.88 -0.06 (-0.86%)
Closing price 03:58 PM Eastern
Extended Trading
$6.88 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

LFWD vs. IINN, AGPU, ECOR, QTEX, and NYXH

Should you buy Lifeward stock or one of its competitors? MarketBeat compares Lifeward with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lifeward include Inspira Technologies OXY B.H.N. (IINN), Predictive Oncology (AGPU), electroCore (ECOR), Inspira Technologies OXY B.H.N. (QTEX), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

How does Lifeward compare to Inspira Technologies OXY B.H.N.?

Lifeward (NASDAQ:LFWD) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, Lifeward had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 1 mentions for Lifeward and 0 mentions for Inspira Technologies OXY B.H.N.. Lifeward's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company Overall Sentiment
Lifeward Neutral
Inspira Technologies OXY B.H.N. Neutral

26.8% of Lifeward shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Lifeward has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Lifeward's return on equity.

Company Net Margins Return on Equity Return on Assets
Lifeward-123.66% -243.14% -97.39%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Lifeward.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lifeward$22.03M0.88-$19.91M-$19.66N/A
Inspira Technologies OXY B.H.N.$289K211.46-$13.22MN/AN/A

Lifeward presently has a consensus price target of $10.00, suggesting a potential upside of 45.35%. Given Lifeward's stronger consensus rating and higher probable upside, equities research analysts clearly believe Lifeward is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Inspira Technologies OXY B.H.N. beats Lifeward on 7 of the 13 factors compared between the two stocks.

How does Lifeward compare to Predictive Oncology?

Lifeward (NASDAQ:LFWD) and Predictive Oncology (NASDAQ:AGPU) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Lifeward has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Predictive Oncology has a beta of 3.47, indicating that its stock price is 247% more volatile than the broader market.

Lifeward has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lifeward$22.03M0.88-$19.91M-$19.66N/A
Predictive Oncology$120K583.38-$233.10M-$8.18N/A

In the previous week, Predictive Oncology had 1 more articles in the media than Lifeward. MarketBeat recorded 2 mentions for Predictive Oncology and 1 mentions for Lifeward. Predictive Oncology's average media sentiment score of 0.76 beat Lifeward's score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the news media.

Company Overall Sentiment
Lifeward Neutral
Predictive Oncology Positive

Lifeward has a net margin of -123.66% compared to Predictive Oncology's net margin of -470,383.31%. Lifeward's return on equity of -243.14% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Lifeward-123.66% -243.14% -97.39%
Predictive Oncology -470,383.31%-7,363.67%-626.32%

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 1.2% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 45.35%. Given Lifeward's stronger consensus rating and higher possible upside, equities analysts clearly believe Lifeward is more favorable than Predictive Oncology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Lifeward beats Predictive Oncology on 11 of the 16 factors compared between the two stocks.

How does Lifeward compare to electroCore?

Lifeward (NASDAQ:LFWD) and electroCore (NASDAQ:ECOR) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

electroCore has higher revenue and earnings than Lifeward. electroCore is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lifeward$22.03M0.88-$19.91M-$19.66N/A
electroCore$32.03M1.86-$13.97M-$1.77N/A

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 13.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, electroCore had 1 more articles in the media than Lifeward. MarketBeat recorded 2 mentions for electroCore and 1 mentions for Lifeward. electroCore's average media sentiment score of 1.27 beat Lifeward's score of 0.00 indicating that electroCore is being referred to more favorably in the news media.

Company Overall Sentiment
Lifeward Neutral
electroCore Positive

Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 45.35%. electroCore has a consensus target price of $18.00, indicating a potential upside of 150.35%. Given electroCore's stronger consensus rating and higher probable upside, analysts clearly believe electroCore is more favorable than Lifeward.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Lifeward has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, electroCore has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

electroCore has a net margin of -44.08% compared to Lifeward's net margin of -123.66%. Lifeward's return on equity of -243.14% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
Lifeward-123.66% -243.14% -97.39%
electroCore -44.08%-1,956.38%-83.30%

Summary

electroCore beats Lifeward on 12 of the 15 factors compared between the two stocks.

How does Lifeward compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its stock price is 311% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market.

In the previous week, Inspira Technologies OXY B.H.N. had 5 more articles in the media than Lifeward. MarketBeat recorded 6 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Lifeward. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.79 beat Lifeward's score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Positive
Lifeward Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Lifeward's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Lifeward -123.66%-243.14%-97.39%

Lifeward has a consensus target price of $10.00, suggesting a potential upside of 45.35%. Given Lifeward's stronger consensus rating and higher probable upside, analysts plainly believe Lifeward is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Lifeward.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$290K203.30-$13.22MN/AN/A
Lifeward$22.03M0.88-$19.91M-$19.66N/A

Summary

Inspira Technologies OXY B.H.N. beats Lifeward on 9 of the 14 factors compared between the two stocks.

How does Lifeward compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Nyxoah currently has a consensus price target of $7.00, indicating a potential upside of 329.45%. Lifeward has a consensus price target of $10.00, indicating a potential upside of 45.35%. Given Nyxoah's stronger consensus rating and higher possible upside, equities analysts plainly believe Nyxoah is more favorable than Lifeward.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67

26.8% of Lifeward shares are held by institutional investors. 17.1% of Nyxoah shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Nyxoah had 6 more articles in the media than Lifeward. MarketBeat recorded 7 mentions for Nyxoah and 1 mentions for Lifeward. Lifeward's average media sentiment score of 0.00 beat Nyxoah's score of -0.02 indicating that Lifeward is being referred to more favorably in the news media.

Company Overall Sentiment
Nyxoah Neutral
Lifeward Neutral

Nyxoah has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market.

Lifeward has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$11.33M5.58-$101.92M-$2.48N/A
Lifeward$22.03M0.88-$19.91M-$19.66N/A

Lifeward has a net margin of -123.66% compared to Nyxoah's net margin of -543.21%. Nyxoah's return on equity of -163.73% beat Lifeward's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-543.21% -163.73% -80.24%
Lifeward -123.66%-243.14%-97.39%

Summary

Nyxoah beats Lifeward on 10 of the 16 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFWD vs. The Competition

Export
MetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market Cap$19.53M$15.96B$38.14B$12.27B
Dividend YieldN/A3.54%3.30%5.87%
P/E Ratio-0.3558.87170.7023.97
Price / Sales0.8839.09622.39101.45
Price / CashN/A67.7246.3353.91
Price / Book1.256.139.566.32
Net Income-$19.91M$384.51M$1.07B$337.22M
7 Day Performance-0.43%-2.16%-2.06%-1.20%
1 Month Performance-2.41%-5.28%0.29%0.40%
1 Year Performance-6.32%-10.46%155.99%29.26%

Lifeward Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFWD
Lifeward
2.1175 of 5 stars		$6.88
-0.9%		$10.00
+45.3%		-40.3%$19.53M$22.03MN/A60
IINN
Inspira Technologies OXY B.H.N.
0.6248 of 5 stars		$2.08
-5.5%		N/A+128.9%$74.77M$289KN/A20
AGPU
Predictive Oncology
0.9007 of 5 stars		$6.82
-7.9%		N/AN/A$73.74M$50.29KN/A30
ECOR
electroCore
4.1343 of 5 stars		$8.88
+2.3%		$18.00
+102.7%		+39.9%$73.67M$34.90MN/A50
QTEX
Inspira Technologies OXY B.H.N.
1.2211 of 5 stars		$1.98
-4.6%		N/AN/A$71.33M$290KN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:LFWD) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel